May 24, 2011 (New York, New York) — The use of the combination therapy azilsartan medoxomil (Edarbi, Takeda Pharmaceuticals) and chlorthalidone resulted in a more effective reduction in systolic blood ...

Please provide your email address to receive an email when new articles are posted on . Combination azilsartan medoxomil and chlorthalidone was shown to be superior to combination olmesartan medoxomil ...

Deerfield, Ill., February 6, 2012 and Osaka, Japan, February 7, 2012 - Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda ...

May 4, 2010 (New York, New York) — Data on a new angiotensin-receptor blocker (ARB), azilsartan (Takeda Pharmaceuticals), have been presented here at the American Society of Hypertension (ASH) 2010 ...

Blood pressure reductions statistically superior to olmesartan medoxomil-hydrochlorothiazide June 19, 2012 Results of a 12-week, head-to-head, phase 3 study published online in the American Heart ...

Up-to-date prescription details regarding Azilsartan Medoxomil and Chlorthalidone are provided here. Understand it's uses, recommended dosages, its indications, how to take, when to take, when not to ...

Ahmedabad: Zydus Lifesciences Limited has received tentative approval from the US Food and Drug Administration (US FDA) to market Azilsartan Medoxomil and Chlorthalidone tablets, 40 mg/12.5 mg and 40 ...

Mumbai, 16th May, 2017 : Mankind Pharma, a quality driven pharmaceutical company in India launches Anti-Hypertensive-drug Zolahart (Azilsartan), at an affordable price of Rs 7.50 per tablet. Aiming at ...

Takeda says it has completed settlements with six out of eight defendants in patent infringement litigation concerning possible generic versions of the Japanese drugmaker’s diabetes blockbuster Actos ...